Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Schenkein David P
Relationship:   Director
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   174,790    

Indirect Shares

  417,826      
Direct Value   $6,163,557    

Indirect Value

  $16,623,289      
Total Shares   592,616      
Total Value   $22,786,845      


Agios Pharmaceuticals Inc
 $5,419,090 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,556 Denali Therapeutics Inc.
 $445,612 Regeneron Pharmaceuticals Inc
 $292,299 Agios Pharmaceuticals Inc
 $5,419,090 Foundation Medicine, Inc.
 $0 Bluebird Bio, Inc.
 $6,556 Denali Therapeutics Inc.
 $445,612 Regeneron Pharmaceuticals Inc
 $292,299
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    3    

     Stock price went up :

    0   
    3    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   3.0   
     Percentage Gain/Loss :
     0.0%
 118.4%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agios Pharmaceuticals Inc AGIO Director 2024-02-27 122,854 2024-02-27 349,854    Premium*  
            Foundation Medicine, Inc. FMI Director 2016-06-16 23,326 2016-06-16 10,508    Premium*  
            Bluebird Bio, Inc. BLUE 2020-06-18 6,832 2014-12-19 0    Premium*  
            Denali Therapeutics Inc. DNLI Director 2024-05-31 21,496 2024-05-31 57,464    Premium*  
            Regeneron Pharmaceuticals Inc REGN Director 2024-01-02 282 2023-09-08 0    Premium*  
* Premium Members only  

Records found :    154         Free Registration Required For Full Results.    Limit: 25

Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
DNLI Denali Therapeutics Inc. Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 4,216 15,529 0 -
AGIO Agios Pharmaceuticals Inc Director   –       •      –    2023-06-21 4 OE $0.00 $0 D/D 4,975 122,854 0 -
REGN Regeneron Pharmaceuticals... Director   –       •      –    2023-09-08 4 A $0.00 $0 D/D 240 240 0 -
REGN Regeneron Pharmaceuticals... Director   –       •      –    2024-01-02 4 A $0.00 $0 D/D 42 282 0 -
DNLI Denali Therapeutics Inc. Director   –       •      –    2024-05-31 4 A $0.00 $0 D/D 5,967 21,496 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-03-10 4 OE $0.30 $16,335 I/I 54,000 241,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-03-25 4 OE $0.30 $7,563 I/I 25,000 266,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-02 4 OE $0.30 $1,966 I/I 6,500 259,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-09-26 4 OE $0.30 $9,075 I/I 30,000 283,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2014-10-01 4 OE $0.30 $756 I/I 2,500 255,772 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-02-27 4 OE $0.30 $7,563 I/I 25,000 248,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-05-07 4 OE $0.30 $3,025 I/I 10,000 241,372 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2015-08-03 4 OE $0.30 $231,152 I/I 8,000 240,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2016-01-04 4 OE $0.30 $3,025 I/I 10,000 242,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2016-01-05 4 OE $0.30 $3,025 I/I 10,000 252,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2016-01-07 4 OE $0.30 $6,050 I/I 20,000 272,272 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-02-16 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-04-03 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-05-01 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-06 4 OE $0.30 $333 D/D 1,100 1,100 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-06-07 4 OE $0.30 $575 D/D 1,900 1,900 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-07-03 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-01 4 OE $0.30 $908 D/D 3,000 3,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-08-02 4 OE $0.30 $7,260 D/D 24,000 24,000 0 -
AGIO Agios Pharmaceuticals Inc Chief Executive Officer   •       •      –    2017-09-01 4 OE $0.30 $1,815 D/D 6,000 6,000 0 -

  154  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed